Researchers conducted a study to assess the safety and efficacy of aminoglycosides or polymyxin monotherapy for the treatment of adults with complicated urinary tract infections caused by extensively drug-resistant Pseudomonas aeruginosa.
Researchers conducted a study to determine whether a double-dose of cefuroxime decreases the risk for surgical site infections in patients weighing at least 80 kg.
Researchers conducted a study to compare the effects of intravenous vs oral antibiotics therapy in patients with a pulmonary infection caused by Pseudomonas aeruginosa secondary to cystic fibrosis.
Researchers conducted a study to determine whether the addition of azithromycin to standard care decreases the risk of mortality among children with acute watery diarrhea.
Investigators assessed whether daily bathing with 2% chlorhexidine gluconate decreases the risk for vancomycin-resistant enterococci (VRE) transmission in an intensive care unit with increased VRE endemicity.
Researchers conducted a study to determine whether C-reactive protein (CRP) velocity is effective for differentiating between acute viral and bacterial infections in patients with relatively decreased CRP concentrations.
Does the prescription of antibiotics provide a meaningful clinical benefit for children who present with uncomplicated lower respiratory tract infections?
Investigators conducted a study to assess the frequency at which changes in antimicrobial susceptibility patterns occur among bacterial species isolated from the same patient.
Researchers conducted a study to compare the effects of short- vs long-course antibiotics for the treatment of bloodstream infections in patients with acute myeloid leukemia and chemotherapy-induced febrile neutropenia.
Researchers conducted a study to determine whether a prolonged infusion time increases the efficacy of meropenem for the treatment of patients hospitalized with severe pneumonia.
Researchers conducted a study to assess the effect of doxycycline treatment on the risk for 30 and 90-day all-cause mortality in older adults hospitalized with community-acquired pneumonia.
Researchers conducted a multicenter analysis that compared the ability of 3 nucleic acid amplification tests to detect extragenital Chlamydia trachomatis and Neisseria gonorrhoeae infections in oropharyngeal and anorectal swab specimens.
Investigators assessed the safety and efficacy of two 1-week quadruple therapies given consecutively in patients with difficult-to-treat Helicobacter pylori infections.
Researchers conducted a study to determine the monetary effect of a surgical care bundle for the prevention of surgical site infections among patients undergoing craniotomy procedures.
![Staphylococcus aureus is a rare cause of myocarditis and typically affects immunocompromised patients with sepsis. S aureus myocarditis usually occurs with endocarditis and may result in the formation of abscesses on the heart valves and muscle.5 “As with viral myocarditis, this disease can present with signs and symptoms of acute myocardial infarction, complicating the diagnosis,” wrote the authors of a 2008 case study.12 “Much of the available data on bacterial myocarditis [were] collected before the development of many modern diagnostic tests and before antibiotics [thus] the appropriate workup, diagnosis and treatment remain unclear.”12 A case report published in 2018 described a 44-year-old man with rheumatoid arthritis taking methotrexate who was diagnosed with S aureus myocarditis (and associated left ventricular apical thrombus) after having septic shock.13 Complete recovery was achieved with a 12-week course of antibiotics and anticoagulation.](https://www.infectiousdiseaseadvisor.com/wp-content/uploads/sites/16/2021/03/7staphylococcusaureusgetty1_1479047.jpg)
![Staphylococcus aureus is a rare cause of myocarditis and typically affects immunocompromised patients with sepsis. S aureus myocarditis usually occurs with endocarditis and may result in the formation of abscesses on the heart valves and muscle.5 “As with viral myocarditis, this disease can present with signs and symptoms of acute myocardial infarction, complicating the diagnosis,” wrote the authors of a 2008 case study.12 “Much of the available data on bacterial myocarditis [were] collected before the development of many modern diagnostic tests and before antibiotics [thus] the appropriate workup, diagnosis and treatment remain unclear.”12 A case report published in 2018 described a 44-year-old man with rheumatoid arthritis taking methotrexate who was diagnosed with S aureus myocarditis (and associated left ventricular apical thrombus) after having septic shock.13 Complete recovery was achieved with a 12-week course of antibiotics and anticoagulation.](https://www.infectiousdiseaseadvisor.com/wp-content/uploads/sites/16/2021/03/7staphylococcusaureusgetty1_1479047-150x150.jpg)
